Triumeq PD
abacavir sulfate, dolutegravir sodium, lamivudine · KIT · ViiV Healthcare Company
No Recall History
Plain English
Triumeq PD is a kit containing abacavir sulfate, dolutegravir sodium, lamivudine. Manufactured by ViiV Healthcare Company.
Key Facts
- Brand Name
- Triumeq PD
- Generic Name
- abacavir sulfate, dolutegravir sodium, lamivudine
- NDC Code (Product)
49702-258- Manufacturer
- ViiV Healthcare Company
- Dosage Form
- KIT
- Marketing Status
- Application #
- NDA215413
- Drug Class
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
- Marketing Start
- 03/30/2022
Recall History
No Recall HistoryFrequently Asked Questions
What is Triumeq PD used for?
Triumeq PD contains abacavir sulfate, dolutegravir sodium, lamivudine. It is a kit taken as directed. Consult your doctor for specific uses.
Is Triumeq PD a controlled substance?
Triumeq PD is not classified as a controlled substance by the DEA.
What is the generic name for Triumeq PD?
The generic name for Triumeq PD is abacavir sulfate, dolutegravir sodium, lamivudine. There are 1 other brand versions of abacavir sulfate, dolutegravir sodium, lamivudine.
What is the NDC code for Triumeq PD ?
The NDC (National Drug Code) for Triumeq PD is 49702-258, listed by ViiV Healthcare Company.